Description
Technical & Manufacturing Relevance:
Traditionally used as a cardioactive, expectorant, diuretic, and anti-inflammatory herbal active in controlled-dose Ayurvedic and Unani formulations.
Employed in formulations for respiratory congestion, asthma, bronchitis, edema, and cardiovascular-support therapies (traditional use).
Due to the presence of potent cardiac glycosides, strict standardization, dose control, and regulatory compliance are mandatory for manufacturing and export.
Suitable for aqueous and hydroalcoholic extraction with validated detoxification and standardization protocols.
Compatible with GMP-compliant granulation, encapsulation, tableting, and liquid-extract manufacturing under regulated conditions.
Applicable Dosage Forms:
Tablets & capsules (low-dose, standardized)
Powders & granules (formulator-controlled use)
Liquid extracts, drops & syrups
Classical Ayurvedic and Unani formulations
Pharmaceutical-support preparations (where permitted)
Pharmacopoeial / Quality Notes:
Referenced in Ayurvedic Pharmacopoeia of India (API) and Unani pharmacopeial literature
Export-grade material aligned with international phytopharmaceutical quality standards
Typical quality parameters:
Assay: total cardiac glycosides / bufadienolides (HPLC)
Loss on drying: ≤8–10%
Glycoside fingerprinting and toxicity profiling mandatory
Microbial limits, aflatoxins, heavy metals, and pesticide residues within international limits
End-use declaration and regulatory review required for many importing countries.
Animal-Origin Declaration:
100% plant origin. No animal-derived ingredients.
Manufacturing Support:
Offered for contract manufacturing, third-party manufacturing, private labeling, and white labeling only for regulated herbal and phytopharmaceutical applications.
Full technical and regulatory documentation provided, including COA, MSDS, TDS, stability data, non-GMO statement, glycoside assay reports, safety/toxicity validation, and export-compliant regulatory documents, enabling controlled resale and distribution in approved international markets.
